Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora

NCT04366089 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

152

Enrollment

OTHER

Sponsor class

Conditions

COVID
SARS-CoV 2
Pneumonia, Viral
Coronavirus Infection

Interventions

OTHER: Oxygen-ozone therapy, probiotic supplementation and Standard of care
DIETARY_SUPPLEMENT: SivoMixx (200 billion)
DRUG: Azithromycin
DRUG: hydroxychloroquine

Sponsor

Roberto Poscia MD, PhD